Stock 603233 DASHENLIN PHARMACEUTICAL GROUP CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights DaShenLin Pharmaceutical Group Co., Ltd.

Equities

603233

CNE100002RG2

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-05-27 pm EDT 		5-day change 1st Jan Change
20.3 CNY -1.55% Intraday chart for DaShenLin Pharmaceutical Group Co., Ltd. -10.18% -18.47%
Apr. 28 DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Apr. 28 DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Dashenlin Pharmaceutical to Buy Back Up to 200 Million Yuan Shares
MT
Dashenlin Pharmaceutical Plans to Buy Back Up to 200 Million Yuan Worth of Shares
MT
Dashenlin Pharmaceutical to Boost Stake in Local Pharmacy Chain to 66% For 30 Million Yuan
MT
DaShenLin Pharmaceutical Group Co., Ltd. agreed to acquire 15% stake in Chongqing Wanjiayan Pharmacy Chain Co., Ltd from Chongqing Wanjiayan Health Industry Group Co., Ltd. and Bai Run for CNY 30 million.
CI
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Beijing Mulls Banning Internet Healthcare Firms From Selling Drugs Online
MT
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
CI
Dashenlin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
Dashenlin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
Dashenlin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
CI
DaShenLin Pharmaceutical Group Co., Ltd. cancelled the acquisition of 51% stake in Nantong Jianghai Pharmacy Chain Co., Ltd. from Zhenjiang New District Dingjun Enterprise Management Center (Limited Partnership) and Zhenjiang New District Dingjun Enterprise Management Center (Limited Partnership).
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 603233 Stock
  4. News DaShenLin Pharmaceutical Group Co., Ltd.
  5. Highlights